Cargando…

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium

Detalles Bibliográficos
Autores principales:	Allen, Bradley D, Chatterjee, Neil, Ayache, Jad Bou, Freed, Benjamin H, Lee, Daniel C, Carroll, Timothy, Markl, Michael, Collins, Jeremy D, Carr, James C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328754/ http://dx.doi.org/10.1186/1532-429X-17-S1-P113

Ejemplares similares

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Inter-study reproducibility of cardiac MRI in free breathing patients at rest for the evaluation of regional myocardial perfusion
por: DeSa, Travis, et al.
Publicado: (2016)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Right-ventricular assessment using a segmented cine acquisition employing iterative SENSE reconstruction with spatio-temporal L1 regularization: Initial clinical experience
por: Bogachkov, Abraham, et al.
Publicado: (2016)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy
por: Husain, Nazia, et al.
Publicado: (2021)

Trisodium scandium bis(orthoborate)
por: Fang, Jinzhi, et al.
Publicado: (2012)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

The validity of a free breathing motion corrected phase sensitive inversion recovery sequence in the detection of delayed myocardial enhancement in non-ischemic heart disease
por: Flanagan, Oisin, et al.
Publicado: (2014)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Application of feature tracking at cine cardiac MR for the semiautomated prediction of normal right ventricular systolic function: a feasibility study
por: Botelho, Marcos, et al.
Publicado: (2014)

Diagnosis of chronic allograft vasculopathy using semiquantitative stress perfusion CMR in heart transplant patients
por: Schwid, Madeline, et al.
Publicado: (2016)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson
por: Lyons, Matthew, et al.
Publicado: (2012)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Pseudohypernatremia secondary to trisodium citrate (Citra-Lock(TM))
por: Milliere, Janice, et al.
Publicado: (2016)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Incorporating time-resolved three-dimensional phase contrast (4D flow) MRI in clinical workflow: initial experiences at a large tertiary care medical center
por: Allen, Bradley D, et al.
Publicado: (2013)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Measurement of diastolic left ventricular function with ultra-fast phase contrast MRI
por: Chatterjee, Neil, et al.
Publicado: (2011)

Reinvestigation of trisodium dihydroxidotetraoxidoneptunate(VII) dihydrate
por: Grigoriev, Mikhail S., et al.
Publicado: (2007)

Gadofosveset trisodium in coronary magnetic resonance angiography at 3 Tesla
por: Raman, Fabio S, et al.
Publicado: (2014)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bg6g57g5mqfmpq7f3ojp9ecvbc